Short Interest & Thesis

Short Interest & Thesis — The Trade Desk (TTD)

Bottom line. Official reported short interest for TTD is not available in the staged data — the FINRA equity short-interest feed returned zero position rows, and no short-sale-volume, borrow-cost, public net-short, or peer-crowding rows were staged either. So this page is not a squeeze/crowding read; it is a thesis-risk assessment built from the primary record. And that record is unusually rich: TTD has lost roughly 86% of its value in eighteen months on repeated 30–40% earnings gap-downs, and the disclosed short case is not a forensic-fraud case (the company is profitable, net-cash, and free-cash-flow generative) but a governance + competition + de-rating case — founder super-voting control just under a majority [1], a pending securities class action that now adds a Section 20A insider-trading claim against the CEO, CFO and CSO [2], the resignation of all three audit-committee members in early 2026 [3], and an Amazon-led walled-garden competitive threat [4].

What is (and isn't) in the data

The short-interest data step staged the file scaffold but every position table came back empty.

Source: reported short-interest / short-sale-volume / borrow / peer figures as staged (all empty); narrative from TTD SEC filings and transcripts.

Because there is no official short position, no legitimate "days-to-cover" or "% of float short" can be computed. Anyone quoting a TTD short-interest number here would be inventing it. The honest institutional answer on positioning is: not decision-useful in this dataset. The decision-useful content is the thesis-risk ledger and the tape.

Tape and liquidity context (inferred — not short interest)

What the price series can tell us is that TTD trades like a crowded, negative-momentum name: a violent, multi-quarter de-rating on rising volume.

Source: staged daily price series (data/prices/), month-open close, split-adjusted; not a filing figure.

The stock peaked near $135 (Dec 2024) and trades near $19 (Jul 2026) — roughly an 86% drawdown. This is the tape a short thesis would point to as vindication. Note the mechanics: TTD reports and then gaps, hard, in both directions. Two of the largest single-day moves in the company's history were earnings-driven collapses.

Source: staged daily price series (data/prices/); percentage moves derived from reported closes — not a filing figure.

Read for a PM: the same catalyst sensitivity that produced −33% (Feb 2025) and −39% (Aug 2025) also produced +33% and +36% up-gaps in prior beats. A short here carries real positive-catalyst / squeeze-into-a-beat risk even without a confirmed crowded position — the name is a coiled spring around every quarterly print. Liquidity, however, is deep: recent volume has averaged roughly 19 million shares/day against ~494 million shares outstanding, so an exit is not the constraint a short would worry about.

Source: shares outstanding from FY2025 10-K financial data (data/financials/); ADV derived from staged daily price series (data/prices/).

The short-thesis ledger (grounded in TTD's own disclosures)

There is no staged short-seller report, so this ledger is assembled from the company's own filings — the disclosures a short would build a case on, each paired with management's framing where it exists. This is the substance of the page.

Sources: FY2025 10-K risk factors and Note 13 [5] [6]; proxy [7]; Q4 FY2024 transcript [8].

Governance: the strongest, most durable leg

Insiders control roughly 49.9% of total voting power through the 10-votes-per-share Class B structure — "this concentrated control limits or precludes your ability to influence corporate matters" in the company's own words [9]. The proxy shows CEO Jeff Green holding 42,071,879 Class B shares across his trusts, the source of that voting block [10]. Layered on top: the November 2024 reincorporation to Nevada, whose interested-stockholder statute restricts 10%+ holders and whose forum provisions channel disputes away from Delaware Chancery [11]. A short frames this as governance that tilts hard toward the founder and away from minority holders.

The sharpest recent signal is the audit committee: all three members — Kathryn Falberg, Lise Buyer and Gokul Rajaram — resigned from the board within two weeks of each other in late March / early April 2026 [12]. Three simultaneous audit-committee departures is exactly the sort of event a short thesis elevates, whatever the benign explanations may be.

The CEO performance option — a 2021 ten-year grant vesting on share-price targets up to $340 — was itself litigated in the Huizenga v. Green derivative suit alleging the board breached its duties in approving it; the dismissal was ultimately affirmed on appeal in November 2025 [13] [14]. That one resolved in the company's favor; the open item is the securities case.

The litigation: an unresolved Section 20A overhang

Following the February 2025 stock collapse, securities class actions were filed [15], and the consolidated amended complaint now asserts a separate Section 20A claim that the CEO, then-CFO and Chief Strategy Officer "engaged in insider trading during the proposed class period," on top of the Section 10(b) fraud-on-the-market claims [16]. This is unresolved (motion to dismiss pending) and is the single most citable "hard" short-thesis hook — it links insider selling to the very disclosures that preceded an 80%+ decline. It is an allegation, not a finding; the company contests it.

The business case: competition and a self-inflicted miss

TTD concedes that walled-garden inventory providers "may exclusively sell their own inventory directly to advertisers, which prevents us from competing with them entirely for such inventory" — the structural Amazon/Google/Meta risk [17]. Client stickiness is thin on paper: master service agreements carry "no material commitments" and are "terminable at any time upon 60 days' notice" [18], and concentration is real — two agency holding companies each represented more than 10% of gross billings in 2025 [19].

Crucially, management handed the short case its narrative. On the Q4 FY2024 call the CEO acknowledged that "for the first time in 33 quarters as a public company we fell short of our expectations," attributing it to "a series of small execution missteps" during the Kokai platform migration — self-inflicted, not competitive [20]. Growth then kept slowing: Q3 FY2025 was guided to "at least $717 million, reflecting 14% year-over-year growth," with explicit tariff/macro caveats around large global brands [21].

Source: FY2025 10-K financial data, revenue by year (data/financials/); growth rates derived. Guidance quote at Q2 FY2025 transcript [22].

The counter to a forensic short: the balance sheet doesn't cooperate

The reason this is a governance-and-multiple short rather than a fraud-and-solvency short: TTD's financials are strong. It is profitable, throws off cash, and holds no meaningful debt — none of the going-concern, covenant, or burn stress a classic activist short leans on.

Source: FY2025 10-K financial data — income, cash flow, balance sheet (data/financials/).

That cash funds a large buyback, which the company runs partly to offset equity-comp dilution — but it warns in its own risk factors that repurchases "cannot guarantee… that it will successfully mitigate the dilutive effect of employee equity awards" and that they "diminish our cash reserves" [23]. Share count has stayed roughly flat despite heavy issuance because the buyback ran hot — $1.4B in FY2025.

Source: FY2025 10-K financial data, cash-flow financing detail (data/financials/); dilution-offset caveat at FY2025 10-K [24].

Peer context

Unavailable. No peer short-interest rows were staged, so no cross-name crowding comparison is possible. For reference, TTD's own filings frame its competitive set as the independent DSPs and, more pressingly, the walled gardens (Amazon, Google, Meta) [25]; the indexed peer set includes Viant (DSP), Criteo (CRTO) and Amazon (AMZN). A relative-crowding read would require reported short interest for both TTD and those peers, which this run does not have.

Evidence quality

Source: staged data/short_interest/ manifest (all position tables empty); narrative items cite the TTD filings referenced above.